Breakthroughs and Setbacks: New Data Highlights Promise and Risk in Cell and Gene Therapies 10 months ago JohnIn Biopharma HighlightsPharma Industry Updates
Biodexa Pharmaceuticals Reports Interim Results Highlighting Strategic Advances in Rare Disease Pipeline and Clinical Progress 10 months ago JohnIn Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
Atea Pharmaceuticals Advances Global Phase 3 HCV Program with First Patient Dosed in C-FORWARD Outside North America 10 months ago JohnIn Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals 10 months ago JohnIn Biopharma ManufacturingInnovationLeadersPharma Industry Updates
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence 11 months ago JohnIn Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast 11 months ago JohnIn Biopharma HighlightsClinical TrialsInnovationInvestments
Viking Therapeutics Launches Phase 3 VANQUISH Program for VK2735 in Obesity and Type 2 Diabetes 11 months ago JohnIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Metabolics Pharma Announces Positive Topline Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects 11 months ago JohnIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
MaaT Pharma Delivers Business Update Amid Positive Clinical and Commercial Milestones 11 months ago JohnIn Biopharma HighlightsClinical TrialsInnovationPartnershipsPharma Industry Updates
CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials, Offering New Hope for Obesity and Type 2 Diabetes Management 11 months ago JohnIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Ocular Therapeutix Advances OTX-TKI Axitinib Hydrogel with Positive Phase 1/2 and Registrational Trial Data 11 months ago JohnIn Biopharma ManufacturingClinical TrialsInnovationPharma Industry UpdatesTechnology
FDA Approves Dupilumab for Bullous Pemphigoid in Landmark Win for Sanofi and Regeneron 11 months ago JohnIn Biopharma HighlightsClinical TrialsFDA ApprovalsPeoplePharma Industry Updates
FDA Approves Nitisinone (HARLIKU) for Alkaptonuria: First Therapy for Rare Genetic Disorder Marks Milestone in Metabolic Disease 11 months ago JohnIn BreakthroughsFDA ApprovalsPeopleResearch Updates
Zealand Pharma Reports Positive Phase 1b Results for Dual GLP-1/GLP-2 Agonist Dapiglutide in Obesity and Metabolic Disease 11 months ago JohnIn Biopharma HighlightsBreakthroughsClinical TrialsInnovationResearch Updates
Clarity Pharmaceuticals and SpectronRx Announce Major U.S. Manufacturing Deal for 64Cu-SAR-bisPSMA Radiopharmaceutical 11 months ago JohnIn Biopharma ManufacturingClinical TrialsPartnershipsPharma Industry UpdatesTechnology
